| Literature DB >> 31191331 |
Yang Li1, Haiyang Zhang1, Yushi Wang1.
Abstract
The protective role of Tai Chi in coronary heart disease (CHD) has been widely reported. However, the exact molecular mechanism remains unclear. Serum levels of miR-24 and miR-155 have been found to potentially be involved with CHD risk. Thus, the effects of Tai Chi on CHD risk were explored by measuring serum levels of miR-24 and miR-155. A total of 326 CHD patients were evenly divided into the Tai Chi (TG) and control (CG) groups. The activities of daily living ability (ADL) and exercise of self-care agency (ESCA) scores were compared between the two groups. Left ventricular ejection fraction (LVEF), SF-36 life quality, self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were used to evaluate subjects' cardiac function, quality of life, anxiety, and depression. Serum levels of miR-24 and miR-155 were measured by a real-time quantitative polymerase chain reaction (RT-qPCR). After a 6-month Tai Chi intervention, the ESCA, ADL, LVEF, and SF-36 scores in the TG group were higher than those in the CG group (p < 0.05). The time of arrhythmia and atrioventricular block recovery and hospital stay, and the scores of SAS and SDS in the TG group were lower than in the CG group (p < 0.05). Serum levels of miR-24 and miR-155 in the TG group were also lower than in the CG group (p < 0.05). In addition, serum levels of miR-24 and miR-155 were negatively associated with the ESCA, ADL, LVEF and SF-36 scores, and had adverse effects on life quality. Altogether, these present findings demonstrate that Tai Chi improves CHD prognosis, by affecting serum levels of the miR-24 and miR-155.Entities:
Keywords: Tai Chi; cardiac function; coronary heart disease; self-care ability; serum microRNA
Year: 2019 PMID: 31191331 PMCID: PMC6548805 DOI: 10.3389/fphys.2019.00587
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Study flow diagram.
Clinical and demographic characteristics between two groups.
| Tai Chi group ( | Control group ( | |||
|---|---|---|---|---|
| Age (years) | 63.61 ± 6.62 | 65.44 ± 5.79 | 0.101 | 0.759 |
| Gender, male (%) | 72 (44.2) | 68 (41.7) | χ2 = 0.200 | 0.654 |
| BMI, weight/height2 (kg/m2) | 28.9 ± 3.5 | 29.4 ± 3.7 | 1.882 | 0.207 |
| Smoking, cases (%) | 26 (16) | 28 (17.2) | 0.089 | |
| Marital status, married (%) | 145 (89.0) | 149 (91.4) | 0.000 | 1.000 |
| Monthly income, RMB | 4982 ± 3256 | 4618 ± 3029 | 2.456 | 0.127 |
| Region | Changchun city | Changchun city | ||
| Occupation, cases (%) | 0.000 | 1.000 | ||
| Unskilled, cases (%) | 25 (15.3) | 27 (16.6) | ||
| Professional, cases (%) | 78 (47.9) | 75 (46) | ||
| Skilled, cases (%) | 60 (36.8) | 61 (37.4) | ||
| Education | 0.000 | 1.000 | ||
| Elementary, cases (%) | 36 (22.1) | 34 (20.9) | ||
| Middle school, cases (%) | 30 (18.4) | 32 (19.6) | ||
| Professional school, cases (%) | 24 (14.7) | 22 (13.5) | ||
| High school, cases (%) | 43 (26.4) | 42 (25.8) | ||
| University degree, cases (%) | 30 (18.4) | 33 (20.2) | ||
| NYHA class | 0.000 | 0.996 | ||
| I, cases (%) | 36 (22.1) | 38 (23.3) | ||
| II, cases (%) | 49 (30.1) | 58 (35.6) | ||
| III, cases (%) | 77 (47.2) | 67 (41.1) | ||
| IV, cases (%) | 0 | 0 |
Comparison of ESCA score and ADL score before and after nursing care between two groups.
| Groups | ESCA score | ADL score | ||||
|---|---|---|---|---|---|---|
| 0 month | 3 months | 6 months | 0 month | 3 months | 6 months | |
| Tai Chi group | 86.6 ± 11.7 | 96.2 ± 12.6 | 122.5 ± 13.4 | 33. 3 ± 8.3 | 38.2 ± 8.9 | 45.7 ± 6.5 |
| Control group | 87.3 ± 10.7 | 90.3 ± 11.8 | 105.4 ± 12.5 | 32.0 ± 7.6 | 34.1 ± 6.5 | 39.6 ± 4.8 |
| 0.146 | 0.458 | 2.964 | 0.247 | 2.53 | 2.76 | |
| 0.412 | 0.359 | 0.00 | 0.352 | 0.038 | 0.007 | |
Comparison of symptom improvement of CHD patients between two groups.
| Groups | Recovery time of arrhythmia (days) | LVEF% | Recovery time of atrioventricular block (days) | Hospital stay (days) |
|---|---|---|---|---|
| Tai Chi group | 4.5 ± 1.2 | 47.3 ± 3.4 | 3.3 ± 1.6 | 16.4 ± 2.5 |
| Control group | 6.3 ± 1.3 | 42.6 ± 3.1 | 5.5 ± 1.4 | 20.5 ± 4.8 |
| 2.785 | 1.953 | 3.652 | 2.218 | |
| 0.015 | 0.043 | 0.006 | 0.032 |
Comparison of the SF-36 life quality (a score between 0 and 100) between two groups.
| Tai Chi group, | Control group, | ||
|---|---|---|---|
| PF | 33.9 ± 6.9 | 35.1 ± 4. 3 | 0.712 |
| RP | 32.7 ± 5.3 | 34.4 ± 6. 2 | 0.342 |
| RE | 26.2 ± 6.3 | 27.9 ± 5.6 | 0.885 |
| SF | 42.5 ± 4.1 | 41.5 ± 3.1 | 0.873 |
| GH | 56.9 ± 5.8 | 54.5 ± 4.3 | 0.801 |
| BP | 37.6 ± 6.7 | 37.9 ± 3.6 | 0.718 |
| VT | 35.9 ± 3.7 | 38.1 ± 4.1 | 0.523 |
| MH | 45.4 ± 5.3 | 43.3 ± 5.1 | 0.429 |
| Average | 39.5 ± 5.8 | 36. 8 ± 4.9 | 0.278 |
| PF | 45.7 ± 7.4 | 38.9 ± 5.8 | 0.023 |
| RP | 42.8 ± 4.0 | 35.6 ± 5.1 | 0.018 |
| RE | 32.7 ± 4.6 | 28.1 ± 6.5 | 0.032 |
| SF | 53.7 ± 6.3 | 40.1 ± 5.2 | 0.009 |
| GH | 51.4 ± 5.8 | 47.3 ± 3.5 | 0.068 |
| BP | 39.8 ± 6.5 | 38.1 ± 4.0 | 0.187 |
| VT | 41.5 ± 7.3 | 37.2 ± 5.5 | 0.094 |
| MH | 46.0 ± 8.8 | 44.3 ± 6.7 | 0.292 |
| Average | 44.6 ± 6.7∗ | 39.1 ± 4.3∗ | 0.045 |
| PF | 62.1 ± 10.8 | 42.9 ± 6.3 | 0.001 |
| RP | 65.8 ± 3.9 | 36.7 ± 4.1 | 0.001 |
| RE | 61.2 ± 5.7 | 44.9 ± 7.3 | 0.001 |
| SF | 63.4 ± 7.4 | 33.8 ± 5.6 | 0.001 |
| GH | 62.1 ± 6.3 | 56.1 ± 3.7 | 0.014 |
| BP | 54.8 ± 7.2 | 48.8 ± 4.5 | 0.001 |
| VT | 66.7 ± 8.5 | 36.3 ± 6.2 | 0.001 |
| MH | 48.1 ± 9.6 | 42.1 ± 7.3 | 0.042 |
| Average | 61.5 ± 7.4∗ | 40.0 ± 5.3∗ | 0.001 |
Comparison of SAS/SDS scores between groups.
| Groups | SAS | SDS | ||||
|---|---|---|---|---|---|---|
| 0 month | 3 months | 6 months | 0 month | 3 months | 6 months | |
| TG | 55.6 ± 4.6 | 50.1 ± 4.8 | 32.3 ± 4.5 | 57.3 ± 10.5 | 48.3 ± 9.9 | 39.2 ± 9.3 |
| CG | 53.9 ± 6.9 | 53.7 ± 6.1 | 43.9 ± 5.6 | 56.5 ± 6.9 | 54.1 ± 7.0 | 53.6 ± 8.7 |
| 0.263 | 0.398 | 3.598 | 0.156 | 1.826 | 3.247 | |
| 0.512 | 0.256 | 0.001 | 0.672 | 0.039 | 0.003 | |
FIGURE 2The effects of Tai Chi on serum levels of miR-24 and miR-155. (A) the effects of Tai Chi on serum levels of miR-24. (B) the effects of Tai Chi on serum levels of miR-155.
FIGURE 3An association test was used to test the coefficients between serum levels of miroRNA and scores of ESCA, ADL, LVEF and SF-36. (A) The relationship between serum levels of miR-24 and scores of ESCA. (B) The relationship between serum levels of miR-24 and scores of ADL. (C) The relationship between serum levels of miR-24 and scores of LVEF. (D) The relationship between serum levels of miR-24 and scores of SF-36. (E) The relationship between serum levels of miR-155 and scores of ESCA. (F) The relationship between serum levels of miR-155 and scores of ADL. (G) The relationship between serum levels of miR-155 and scores of LVEF. (H) The relationship between serum levels of miR-155 and scores of SF-36. There is a strong negative relationship if rho <−0.5.